Uta Kemmerich-Keil: Merck KGaA to Refrain From Big Deals For Now
Uta Kemmerich-Keil is the head of Merck's corporate finance
German drugmaker Merck KGaA will take a breather from pursuing larger takeover deals as it integrates its latest acquisition Millipore, a company executive said on Tuesday.
"You will not see us involved in transactions of (Millipore's) size in the short term," the company's head of corporate finance, Uta Kemmerich-Keil, said at an event, adding that management's focus was on integrating the laboratory equipment supplier.
Merck agreed to buy U.S. biotech tool maker Millipore for $6 billion in cash in February to diversify away from its pharmaceuticals business.
